Project Grant HT94252310750
Award Date
8/15/23
Completion Date
8/14/26
Dollars Obligated
$1.5M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Miami, FL 33136, USA
Similar Awards
The University of Miami has been awarded a $1,535,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant, effective July 1, 2025 through June 30, 2028, will support advanced biomedical research aimed at targeting reflux-activated oncogenic mRNA translation programs in esophageal adenocarcinoma. This research initiative aligns with the program's focus on transforming healthcare for...
The federal Project Grant award of $1,700,000.00 was provided by the Department of Defense (DoD) through the Military Medical Research and Development (CFDA 12.420) program. The grant was awarded to the University of Miami's Office of Research Administration - School of Medicine Division on September 15, 2024, with a completion date of September 14, 2026. The funding supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the...
The University of Miami received a $921,000 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The three-year award beginning September 15, 2021 will support single-cell analysis of LAG3 checkpoint inhibition in metastatic uveal melanoma. Through this research, the University aims to transform health care for service members and the public by investigating medical solutions for the...
This $1,347,118 Project Grant was awarded on May 15, 2023 by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The funding supports research conducted by the University of Miami to target KIF20A, a kinesin with a novel, non-canonical role in castration-resistant prostate cancer. The research aims to transform health care for Service Members and the American public through innovative and impactful biomedical research investigating medical...
The University of Miami will receive $921,000 through a four-year Project Grant from the Defense Health Agency's Military Medical Research and Development program to conduct research aimed at preventing hair loss in ovarian cancer chemotherapy. The grant period runs from October 1, 2023 through September 30, 2027. Through this award, the University of Miami will leverage its expertise in cancer research to investigate medical solutions that can help reduce the side effects of chemotherapy and...
The University of Miami received a $2,070,414 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) federal grant program. The award, with a performance period from May 1, 2025 to April 30, 2028, will support the university's research into mesenchymal stem cell extracellular vesicle therapies for epidermolysis bullosa. This Project Grant aligns with the program's focus on transforming healthcare for military...
The University of Miami was awarded a $1,036,125 Project Grant from the Defense Health Agency to conduct research titled "TARGETING IMMUNOSUPPRESSIVE ADENOSINE TO ENHANCE VACCINIA VIRUS RENAL CANCER ONCOLYSIS". This 3-year award, running from September 1, 2023 to August 31, 2026, is funded through the Military Medical Research and Development program (CFDA 12.420), which supports biomedical research to transform healthcare for service members and the public. The research seeks to...
The University of Miami's Office of Research Administration - School of Medicine Division received a $1,871,460.00 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "MECHANISMS AND UTILITY OF MULTISENSORY BODY REPRESENTATION IN SCI AND SCI-RELATED NEUROPATHIC PAIN". The grant, with a performance period from Sep 1, 2023 to Aug 31, 2026, will fund research into the mechanisms and applications of...
The University of Miami received a $153,500 Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) to conduct research on "ENGINEERING TARGETED EXOSOME-BASED THERAPEUTICS FOR REPROGRAMMING OF CANCER-ASSOCIATED FIBROBLASTS IN TREATMENT OF CASTRATION-RESISTANT PROSTATE CANCER". The 2-year award period runs from February 15, 2024 to February 14, 2026. The Project Grant supports the university's work to develop novel...
The University of Miami was awarded a $1,272,102 Project Grant from the Defense Health Agency through the Military Medical Research and Development program (CFDA 12.420) to develop proprietary arginine vasopressin receptor type 1A (AVPR1A) antagonists for treatment of lethal prostate cancer. The three-year award beginning May 1, 2023 will support research to investigate medical solutions for battlefield conditions through the support of basic, applied, and advanced biomedical research aimed at...